Tharimmune, Inc.

Ownership Transactions Reported by 11 Insiders

Symbol
THAR on Nasdaq
Location
1200 Route 22 East, Bridgewater, New Jersey

Insiders trading volume in the past year

Tharimmune, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Highpoint Pharmaceuticals LLC 10%+ Owner $489 K Jan 11, 2022
Kufe LLC 10%+ Owner $408 K Jan 11, 2022
Surender Kharbanda 10%+ Owner $363 K Jan 11, 2022
Varinder Kaur 10%+ Owner $328 K Jan 11, 2022
Sandeep Laumas 10%+ Owner $320 K Jan 11, 2022
Randy Milby CEO, Director $78.7 K +$14.6 K +22.7% Dec 15, 2023
Thomas Hess Chief Financial Officer Jan 11, 2022
Kelly Anderson Director May 9, 2023
Lynne Bui Director Nov 7, 2022
Leonard L. Mazur Director Nov 7, 2022
Sireesh Appajosyula Director Nov 7, 2022

Recent Insider Transactions by Companies or Individuals for Tharimmune, Inc.

Insider Class Transaction % Value $ Price $ Shares Shares Owned Date Ownership